Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.77 HKD | +0.73% | +4.14% | -25.74% |
Business Summary
Number of employees: 5,005
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Oncology Drugs
34.5
%
| 2,681 | 38.5 % | 2,345 | 34.5 % | -12.54% |
Central Nervous System Drugs
27.6
%
| 1,538 | 22.1 % | 1,873 | 27.6 % | +21.74% |
Cardiovascular System Drugs
27.5
%
| 1,786 | 25.7 % | 1,865 | 27.5 % | +4.41% |
Alimentary Tract and Metabolism Drugs
7.3
%
| 735 | 10.6 % | 498 | 7.3 % | -32.32% |
Others
3.1
%
| 215 | 3.1 % | 208 | 3.1 % | -3.29% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
81.9
%
| 5,851 | 84.1 % | 5,558 | 81.9 % | -5.01% |
European Union
7.3
%
| 360 | 5.2 % | 497 | 7.3 % | +38.30% |
Asia (Other than China)
7.3
%
| 398 | 5.7 % | 494 | 7.3 % | +23.95% |
Other Countries
3.5
%
| 348 | 5.0 % | 240 | 3.5 % | -31.07% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dian Bo Liu
CEO | Chief Executive Officer | 59 | 02/03/02 |
Rong Bing Yang
PSD | President | 58 | 08/94/08 |
Yun Li Xue
PRN | Corporate Officer/Principal | 60 | 08/94/08 |
Mei Yi Lee
SEC | Corporate Secretary | 56 | 01/20/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Hui Xian Yuan
BRD | Director/Board Member | 65 | 08/94/08 |
Rong Bing Yang
PSD | President | 58 | 08/94/08 |
Dian Bo Liu
CEO | Chief Executive Officer | 59 | 02/03/02 |
Hua Qiao Zhang
BRD | Director/Board Member | 61 | 01/14/01 |
Yuk Lam Lo
BRD | Director/Board Member | 76 | 01/14/01 |
Sze Chung Choy
BRD | Director/Board Member | 65 | 01/14/01 |
Rui Lin Song
BRD | Director/Board Member | 61 | 29/17/29 |
Yuan Yuan Zhu
BRD | Director/Board Member | 43 | 01/09/01 |
Lin Xia
BRD | Director/Board Member | 67 | 25/23/25 |
Dong Lyu
BRD | Director/Board Member | 49 | 06/12 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,549,670,643 | 1,950,149,832 ( 54.94 %) | 0 | 54.94 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
360,596,456 | 70.81% | 465,349,726 $ |
Company contact information
Luye Pharma Group Ltd.
No. 15 Chuang Ye Road High-Tech Industrial Development Zon
264003, Yantai
+
http://www.luye.cnSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.74% | 1.33B | |
+34.00% | 704B | |
+27.07% | 577B | |
-7.75% | 348B | |
+18.53% | 327B | |
+4.95% | 288B | |
+14.89% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.89% | 147B |
- Stock Market
- Equities
- 2186 Stock
- Company Luye Pharma Group Ltd.